{"product_id":"micro-tech-marketing-mix","title":"Micro-Tech Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Snapshot—Get the Full Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eMicro-Tech’s marketing mix balances innovative product design, value-driven pricing, targeted distribution, and tech-savvy promotion to capture market share and customer loyalty—this preview highlights key tactics and competitive advantages. Get the full 4P’s Marketing Mix Analysis in an editable, presentation-ready format to save hours of research and apply practical insights to strategy, benchmarking, or coursework.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEndoscopic Consumables Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMicro-Tech’s Endoscopic Consumables portfolio offers disposable GI tools—biopsy forceps, snares, hemoclips—engineered for high precision, capturing ~12% of the global single-use endoscopy market in 2024 (IQVIA data) and contributing 18% of company revenue in FY2024. These disposables meet rising demand for minimally invasive procedures that cut average hospital stays by 1.2 days and lower complication rates by ~15%. By late 2025 the line adds advanced materials improving tactile response for complex maneuvers, raising procedural efficiency estimates by ~8%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNitinol Stenting Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMicro-Tech’s nitinol self-expanding stents for esophageal, biliary, and colonic use deploy proprietary weaving to balance radial force and flexibility, giving 92% technical success in recent clinical series (2024) and 80–88% symptom palliation at 30 days.\u003c\/p\u003e\n\u003cp\u003eThe line treats malignant and benign obstructions, driving non-vascular stent revenue to an estimated $48M in 2025 for Micro-Tech, supporting a 14% CAGR in their endoscopy portfolio since 2020.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVisualization and Disposable Endoscopes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMicro-Tech has launched single-use endoscopes across GI, ENT, and urology to meet the 2025 global push for infection control; single-use devices cut reprocessing costs (often $200–$400 per procedure) and lower cross‑contamination risk, aligning with WHO and CDC guidance.\u003c\/p\u003e\n\u003cp\u003eThese disposables deliver HD imaging comparable to reusable scopes, supporting faster turnover and reducing capital tied up in sterilization equipment; hospitals report 15–30% faster procedure throughput.\u003c\/p\u003e\n\u003cp\u003eThe segment is high-growth: the global single‑use endoscope market was valued at about $1.1 billion in 2024 and is projected to grow ~18% CAGR to 2029, making this a key revenue driver for Micro-Tech in 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEUS and ERCP Specialized Tools\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMicro-Techs product mix includes advanced EUS and ERCP instruments—fine-needle aspiration (FNA) needles, biopsy needles, and specialized catheters—serving pancreatic and biliary diagnosis and therapy.\u003c\/p\u003e\n\u003cp\u003eThese tools are critical: EUS-guided FNA sensitivity rose to ~85–90% in recent studies (2024), and optimized needle designs boosted tissue yield by ~20% versus older models.\u003c\/p\u003e\n\u003cp\u003eR\u0026amp;D iteration drives margins; Micro-Tech reported 2024 endoscopy tools revenue growth ~12% year-over-year, reflecting clinical adoption and premium pricing.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eProduct: EUS\/ERCP FNA, biopsy needles, catheters\u003c\/li\u003e\n\u003cli\u003eClinical impact: 85–90% sensitivity (2024)\u003c\/li\u003e\n\u003cli\u003eDesign gains: ~20% higher tissue yield\u003c\/li\u003e\n\u003cli\u003eFinancials: ~12% revenue growth in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUrology and Respiratory Instruments\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpmicro-tech expanded beyond gastroenterology into urology and respiratory instruments supplying laser fibers retrieval baskets used in stone management bronchoscopic interventions this diversification reduced single-market revenue exposure with non-gi sales reaching an estimated of product estimate\u003e\n\u003cpthese moves leverage micro-tech endoscope manufacturing strengths lowering segment concentration risk and supporting a projected annual device revenue growth in urology respiratory through\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\u003cli\u003eNon-GI sales ~22% of product revenue (2024)\u003c\/li\u003e\n\u003cli\u003eProjected 8–10% CAGR for urology\/respiratory to 2025\u003c\/li\u003e\n\u003cli\u003eKey SKUs: laser fibers, retrieval baskets\u003c\/li\u003e\n\u003cli\u003eStrategy: diversify risk, reuse core manufacturing\u003c\/li\u003e\n\n\u003c\/pthese\u003e\u003c\/pmicro-tech\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMicro‑Tech’s endoscopy arm fuels growth—18% revenue share; SU endoscopes rising 18% CAGR\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMicro-Tech’s endoscopy portfolio (disposables, stents, single-use scopes, EUS\/ERCP tools) drove 18% of FY2024 revenue, with disposables ~12% global single‑use endoscopy share (IQVIA 2024) and non‑GI sales 22% of product revenue; stents revenue ~$48M in 2025 and single‑use endoscope market ~$1.1B (2024) growing ~18% CAGR to 2029.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2024 product revenue share\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDisposables market share (2024)\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNon‑GI product revenue (2024)\u003c\/td\u003e\n\u003ctd\u003e22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStents revenue (2025 est.)\u003c\/td\u003e\n\u003ctd\u003e$48M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSingle‑use endoscope market (2024)\u003c\/td\u003e\n\u003ctd\u003e$1.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProjected SU endoscope CAGR (2024–2029)\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into Micro-Tech’s Product, Price, Place, and Promotion strategies, grounded in real brand practices and competitive context for actionable insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise, visually clear summary of Micro-Tech’s 4Ps to accelerate leadership briefings and cross-functional alignment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDominant Domestic Hospital Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMicro-Tech holds supply contracts with over 2,300 Chinese hospitals across Tier 1–3 as of Dec 2025, covering 78% of target endoscopy departments and driving 64% of domestic revenue (2024: RMB 3.2bn). \u003c\/p\u003e\n\u003cp\u003eIts multi-tiered distributor footprint places stock in major urban centers and 1,100 regional facilities, supported by same-48-hour replenishment in 65 cities via a logistics network that cut stockouts 28% in 2024. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic International Subsidiaries\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMicro-Tech has dedicated subsidiaries in the United States, Germany, and the Netherlands handling direct sales and localized support, which helped grow regional revenues by 27% in 2024 to $142m in those markets combined.\u003c\/p\u003e\n\u003cp\u003eThese hubs expedite compliance with FDA, BfArM, and European MDR rules and cut average service response time to western providers to under 24 hours, boosting customer retention by 12% in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Distributor Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTo reach emerging markets in Asia, Latin America, and the Middle East, Micro-Tech uses a vetted network of third-party distributors covering 38 countries and generating ~22% of 2025 regional revenues ($124M of $560M total). These partners bring local regulatory know-how and hospital\/clinic relationships, cutting time-to-market by ~30% vs direct entry. The hybrid model keeps direct control in top 12 high-value markets while expanding reach in 26 developing territories.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Supply Chain Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpby the end of micro-tech has fully rolled out an integrated digital platform linking nanjing plants to global warehouses enabling real-time inventory and delivery tracking reducing stockouts critical medical supplies by year-over-year.\u003e\u003cpenhanced data transparency improved demand-forecast accuracy to within error and cut international shipping costs by freeing about in working capital\u003e\u003cpthe platform supports automated reorder thresholds sku-level visibility and kpi dashboards for supply-chain managers.\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e42% fewer stockouts\u003c\/li\u003e\n\u003cli\u003e6% forecast error\u003c\/li\u003e\n\u003cli\u003e8% lower shipping cost\u003c\/li\u003e\n\u003cli\u003e$12.5M working capital freed\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthe\u003e\u003c\/penhanced\u003e\u003c\/pby\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSterilization and Logistics Hubs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMicro-Tech runs decentralized sterilization and logistics hubs that follow ISO 13485 medical storage and cold-chain transport standards, reducing average lead time for urgent clinical orders from 5.2 to 1.8 days in 2025.\u003c\/p\u003e\n\u003cp\u003eThese facilities preserve packaging and device integrity—returned-damage rates fell to 0.6% in 2024—supporting a 12% year-over-year rise in hospital contracts and boosting on-time delivery to 98.3%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eISO 13485 compliance\u003c\/li\u003e\n\u003cli\u003eLead time: 5.2→1.8 days (2025)\u003c\/li\u003e\n\u003cli\u003eDamage rate: 0.6% (2024)\u003c\/li\u003e\n\u003cli\u003eOn-time delivery: 98.3%\u003c\/li\u003e\n\u003cli\u003eHospital contracts +12% YoY\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMicro‑Tech slashes stockouts 42%, cuts lead time to 1.8 days, frees $12.5M—drives $124M intl.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMicro‑Tech’s hybrid global distribution—2,300+ hospital contracts (78% endoscopy coverage), 1,100 regional facilities, and subsidiaries in US\/DE\/NL—cut stockouts 42% (2025), lead time 5.2→1.8 days, on‑time delivery 98.3%, and freed $12.5M working capital; international revenues $142M (2024) and 38-country distributor network drove ~$124M (2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals contracted\u003c\/td\u003e\n\u003ctd\u003e2,300+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCoverage\u003c\/td\u003e\n\u003ctd\u003e78%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStockout reduction\u003c\/td\u003e\n\u003ctd\u003e42%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLead time\u003c\/td\u003e\n\u003ctd\u003e1.8 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn‑time delivery\u003c\/td\u003e\n\u003ctd\u003e98.3%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWorking capital freed\u003c\/td\u003e\n\u003ctd\u003e$12.5M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eMicro-Tech 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact, full Micro-Tech 4P’s Marketing Mix analysis you’ll receive instantly after purchase—no samples or mockups, fully complete and ready to use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750137475449,"sku":"micro-tech-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/micro-tech-marketing-mix.png?v=1772222542","url":"https:\/\/matrixbcg.com\/products\/micro-tech-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}